HNF1A and diabetes mellitus: Although glycomics studies have demonstrated the ability to systematically differentiate HNF1A-MODY patients from other diabetes forms [17, 18], there has not yet been widespread adoption of this approach in clinical environments and currently, testing for MODY depends on the awareness and interest of individual clinicians.